Moderate and Extreme Hypofractionation for Locally Advanced Non-Small Cell Lung Cancer
Evaluating the treatment time slots on the Radixact® System v/s conventional linear accelerator
Evaluating Head & Neck Cancer Patient Experience on the Radixact® System
Radixact® Daily QA: Development of an Efficient, Integrated QA workflow
Establishing a Patient-Specific Quality Assurance Program for Radixact® System: Feasibility of the PTW Octavius 1500 Array for Helical Dose Delivery
Integration of Helical TomoTherapy®, SGRT and Simultaneous Integrated Boost in Pediatric Total Marrow Irradiation: A Case Report
Andre Haraldsson, Ph.D., Skåne University Hospital, Lund, Sweden | ESTRO 2025
Expanding Radixact® System Synchrony® Beyond SBRT: A Prostate Clinical Case Illustration
Xavier Michel, M.D. & Paul Retif, Ph.D., CHR Metz-Thionville, France | ESTRO 2025
Implementing VitalHold™ on the Radixact® System for DIBH in Complex Breast Cancer Treatments: A Clinical Case
Xavier Michel, M.D. & Paul Retif, Ph.D., CHR Metz-Thionville, France | ESTRO 2025
Adjuvant Radiation Therapy in Bladder Cancer: Why, Who and How?
Vedang Murthy, M.D., DNB, DipEPP, Tata Memorial Centre, Mumbai, India | ESTRO 2025
Retour d’expérience Radixact®: évaluation de la stabilité d’unités Hounsfield sur ClearRT®
